Trial Information
Prognostic Factors for Korean Patients With Renal Cell Carcinoma and Venous Tumor Thrombus Extension: Application of the New 2009 TNM Staging System
Inclusion Criteria:
- age ≥ 18 years old
- patients with RCC and venous tumor thrombus who underwent radical nephrectomy and
thrombectomy
Exclusion Criteria:
- von Hippel-Lindau disease
- tuberous sclerosis syndrome
- Wilms' tumor
- synchronous bilateral tumor
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Cancer-specific survival
Outcome Time Frame:
Five years
Safety Issue:
Yes
Principal Investigator
Cheol Kwak, M.D., Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Seoul National University Hospital
Authority:
South Korea: Institutional Review Board
Study ID:
MCCho5
NCT ID:
NCT01328691
Start Date:
March 2011
Completion Date:
March 2011
Related Keywords:
- Carcinoma, Renal Cell
- Thrombus
- Carcinoma, Renal Cell
- thrombus
- body mass index
- grade
- Carcinoma
- Carcinoma, Renal Cell
- Thrombosis